Literature DB >> 25326737

Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.

Robbert C Steggerda1, Kevin Damman2, Jippe C Balt3, Max Liebregts3, Jurriën M ten Berg3, Maarten P van den Berg2.   

Abstract

OBJECTIVES: This study compared alcohol septal ablation (ASA) and surgical myectomy for periprocedural complications and long-term clinical outcome in patients with symptomatic hypertrophic obstructive cardiomyopathy.
BACKGROUND: Debate remains whether ASA is equally effective and safe compared with myectomy.
METHODS: All procedures performed between 1981 and 2010 were evaluated for periprocedural complications and long-term clinical outcome. The primary endpoint was all-cause mortality; secondary endpoints consisted of annual cardiac mortality, New York Heart Association functional class, rehospitalization for heart failure, reintervention, cerebrovascular accident, and myocardial infarction.
RESULTS: A total of 161 patients after ASA and 102 patients after myectomy were compared during a maximal follow-up period of 11 years. The periprocedural (30-day) complication frequency after ASA was lower compared with myectomy (14% vs. 27%, p = 0.006), and median duration of in-hospital stay was shorter (5 days [interquartle range (IQR): 4 to 6 days] vs. 9 days [IQR: 6 to 12 days], p < 0.001). After ASA, provoked gradients were higher compared with myectomy (19 [IQR: 10 to 42] vs. 10 [IQR: 7 to 13], p < 0.001). After multivariate analysis, age (per 5 years) (hazard ratio: 1.34 [95% confidence interval: 1.08 to 1.65], p = 0.007) was the only independent predictor for all-cause mortality. Annual cardiac mortality after ASA and myectomy was comparable (0.7% vs. 1.4%, p = 0.15). During follow-up, no significant differences were found in symptomatic status, rehospitalization for heart failure, reintervention, cerebrovascular accident, or myocardial infarction between both groups.
CONCLUSIONS: Survival and clinical outcome were good and comparable after ASA and myectomy. More periprocedural complications and longer duration of hospital stay after myectomy were offset by higher gradients after ASA.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  alcohol septal ablation; hypertrophic obstructive cardiomyopathy; long-term outcome; myectomy

Mesh:

Substances:

Year:  2014        PMID: 25326737     DOI: 10.1016/j.jcin.2014.05.023

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  19 in total

Review 1.  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.

Authors:  Angelos G Rigopoulos; Stefanos Sakellaropoulos; Muhammad Ali; Sophie Mavrogeni; Athanassios Manginas; Matthias Pauschinger; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

2.  Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation.

Authors:  Srihari S Naidu; Julio A Panza; David Spielvogel; Ramin Malekan; Joshua Goldberg; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2016-12

Review 3.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

4.  Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.

Authors:  Mohammed Osman; Babikir Kheiri; Khansa Osman; Mahmoud Barbarawi; Hani Alhamoud; Fahad Alqahtani; Mohamad Alkhouli
Journal:  Clin Cardiol       Date:  2018-11-29       Impact factor: 2.882

Review 5.  Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelika Batzner; Hans-Joachim Schäfers; Konstantin V Borisov; Hubert Seggewiß
Journal:  Dtsch Arztebl Int       Date:  2019-01-25       Impact factor: 5.594

6.  Unexpected complication of septal ablation 22 years later, septal diverticule with thrombus.

Authors:  İrem Okçular Sezer; Tuğrul Okay
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

7.  Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China.

Authors:  Shuo-Yan An; Yin-Jian Yang; Fei Hang; Zhi-Min Wang; Chao-Mei Fan
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

8.  Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.

Authors:  Lei Yao; Li Li; Xiong-Jun Lu; Yan-Ling Miao; Xiao-Ning Kang; Fu-Jian Duan
Journal:  Cardiovasc Ultrasound       Date:  2016-05-17       Impact factor: 2.062

9.  Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Changlin Zhang; Rong Liu; Jiansong Yuan; Jingang Cui; Fenghuan Hu; Weixian Yang; Yan Zhang; Youzhou Chen; Shubin Qiao
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

10.  Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.

Authors:  Josef Veselka; Lothar Faber; Max Liebregts; Robert Cooper; Jaroslav Januska; Jan Krejci; Thomas Bartel; Maciej Dabrowski; Peter Riis Hansen; Vibeke Marie Almaas; Hubert Seggewiss; Dieter Horstkotte; Radka Adlova; Henning Bundgaard; Jurriën Ten Berg; Rodney Hilton Stables; Morten Kvistholm Jensen
Journal:  J Am Heart Assoc       Date:  2017-05-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.